Schedule 13G ownership disclosure
ONCONOVA THERAPEUTICS INC
Security class unavailable · CUSIP: 68232V405
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 206,730
- Percent of class
- 0.1500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-20-000032
- Form type
- SC 13G
- Filer
- Traws Pharma, Inc.
- CIK
- CIK 1130598
- Filed
- Jan 13, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership